HOME >> BIOLOGY >> NEWS
Record ozone loss during 2006 over South Pole

is season, polar stratospheric clouds are formed that contain chlorine.

As the polar spring arrives, the combination of returning sunlight and the presence of polar stratospheric clouds leads to splitting of chlorine compounds into highly ozone-reactive radicals that break ozone down into individual oxygen molecules. A single molecule of chlorine has the potential to break down thousands of molecules of ozone.

The ozone hole, first recognised in 1985, typically persists until November or December, when the winds surrounding the South Pole (polar vortex) weaken, and ozone-poor air inside the vortex is mixed with ozone-rich air outside it.

Envisat, the largest Earth observation satellite ever built, can localise ozone depletion and track its changes, enabling the rapid estimation of UV radiation as well as providing forecasting. The three atmospheric instruments aboard Envisat are the Scanning Imaging Absorption Spectrometer for Atmospheric Cartography (SCIAMACHY), the global ozone monitoring by occultation of stars (GOMOS) sensor and the Michelson interferometer for passive atmospheric sounding (MIPAS).

In the framework of GMES (Global Monitoring of the Environment and Security), ESA has backed a project named TEMIS (Tropospheric Emission Monitoring Internet Service) that provides operational ozone and UV radiation monitoring based on SCIAMACHY and GOME-1 data. The ozone-monitoring data provided by these instruments span a time period of 11 years, which will be extended by the upcoming MetOp satellite series.

The first MetOp satellite in the series of three is scheduled to be launched in 2006 and will assist climate researchers in monitoring ozone levels and other atmospheric parameters. MetOp Europe's first polar-orbiting satellite and a mission dedicated to operational meteorology will include a next-generation ozone-monitoring instrument called GOME-2, intended to guarantee continuity of observation of this
'"/>

Contact: Mariangela D'Acunto
mariangela.dacunto@esa.int
39-069-418-0856
European Space Agency
2-Oct-2006


Page: 1 2 3

Related biology news :

1. Record number of abstracts submitted for largest scientific congress devoted to osteoporosis
2. Record bonefish
3. Satellite instrument helps tackle mysteries of ozone-eating clouds
4. Overseas NOx could be boosting ozone levels in US
5. Study finds no safe level for ozone
6. New window into ancient ozone holes
7. NASAs aura satellite sheds new light on air quality and ozone hole
8. Study links ozone, mortality in urban areas
9. Ground-level ozone linked to increased mortality
10. Regulating alternative splicing during neural development
11. Burning fat and carbohydrate during exercise

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Record ozone loss during over South Pole

(Date:8/5/2015)... Transparency Market Research has released ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... is forecast to reach US$ 2,671.8 Mn by 2022. ... systems by civil and government agencies. This is majorly ... activities across the globe that would elevate the demand ...
(Date:8/3/2015)... JOSE, Calif. , Aug. 3, 2015 ... of human interface solutions, today announced that members of ... community at the Pacific Crest Global Technology Leadership Forum ... Time. The conference will be held at the Sonnenalp ... The presentation may include forward-looking information. An ...
(Date:7/31/2015)... SHENZHEN , Chine, 31 juillet 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) sera organisée par le ... Shenzhen en Chine. ... année. Depuis son inauguration en 2006, l,ICG est ... influentes dans le domaine des « omiques » et c,est ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
(Date:8/31/2015)... ... August 31, 2015 , ... Regulatory agencies have ... drug development approval process. Thus, innovator companies must understand what will be needed ... Chicago-based CMO, has been hosting multiple educational panels and seminars for experts to ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Global & USA BioSimilar Market Analysis ... The highly awaited US Biosimilar market will be initiated ... biologic, Zarxio. How will the global market react? Will ... that biosimilars could save the US economy up to ...
(Date:8/28/2015)... Texas (PRWEB) , ... August 28, 2015 , ... ... Riordan, PhD and orthopedic surgeon, Wade McKenna, DO, announced today that the use ... Dallas, Texas, resulted in complete healing of an otherwise non-healing surgical knee wound. ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
Breaking Biology Technology:Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
Cached News: